Unbiased HIV Patent Pool — A Free-Market, Middle-Income Countries Open Model 01/04/2010 by Intellectual Property Watch 4 Comments Brand name pharmaceutical companies’ concerns about profit losses related to the UNITAID patent pool might undermine access to newer and appropriate HIV medicine formulations in resource-limited settings. A universally agreed strategy to supplement UNITAID plan is therefore needed, writes Daniele Dionisio.
Mordaz intercambio de puntos de vista en la reunión informativa de la OMS sobre medicamentos falsificados 01/04/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment La Organización Mundial de la Salud (OMS) continúa trabajando en el tema de los medicamentos falsificados, pero la semana pasada una reunión reveló preocupaciones progresivas sobre la forma de conducir la labor.
Semicolon Leads To Breakthrough In Long-Stalled Negotiations 01/04/2010 by Intellectual Property Watch 3 Comments Applause burst from the plenary chamber this week as delegates at last found, in a semicolon, the solution to a long-running and at times sharply divided multilateral negotiation.